千亿·国际(中国)唯一官方网站
Other Affiliated Sites
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
A-Share Information
H-Share Information
2023.12.18
Circular PROPOSED AMENDMENTS TO THE ARTICLES AND RELATED RULES OF PROCEDURES OF...
2023.12.18
ANNOUNCEMENT PROPOSED AMENDMENTS TO THE ARTICLES
2023.12.18
千亿国际:关于召开2024年第一次临时股东大会的通知公告
2023.12.18
千亿国际:关于修订《公司章程》等相关制度的公告
2023.12.18
千亿国际:第六届董事会第六次会议决议公告
2023.12.18
千亿国际:2023年第一次临时股东大会、2023年第一次A股类别股东会议及第一次H股类别股东会...
2023.12.08
千亿国际:关于延长员工持股计划存续期的公告
2023.12.08
千亿国际:第六届董事会第六次会议决议公告
2023.11.23
PROXY FORM FOR THE H SHAREHOLDERS’ CLASS MEETING
2023.11.23
PROXY FORM FOR EXTRAORDINARY GENERAL MEETING
第一页
上一页
12
13
14
15
16
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.